Efficacy and safety of Xianling Gubao capsule in treating postmenopausal osteoporosis

Volume: 100, Issue: 1, Pages: e23965 - e23965
Published: Jan 8, 2021
Abstract
postmenopausal osteoporosis is a systemic metabolic skeletal disease associated with menopause-related estrogen withdrawal. postmenopausal osteoporosis is characterized by low bone mass, bone microstructure destruction, leading to increased bone brittleness and be prone to fracture, resulting in disability and death. At present, the commonly used drugs are estrogen, calcium, bone formation promoter and bone resorption inhibitor, and the side...
Paper Details
Title
Efficacy and safety of Xianling Gubao capsule in treating postmenopausal osteoporosis
Published Date
Jan 8, 2021
Journal
Volume
100
Issue
1
Pages
e23965 - e23965
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.